Alachua, Fla.-based RTI Surgical President and CEO Brian Hutchinson discussed the company's fourth quarter financial results in 2015, according to Seeking Alpha.
Spinal Tech
Followed by North America, Europe holds the next largest neurosurgery market share, based on a Persistence report, according to Medgadget.
The FDA approved Chicago-based St. Jude Medical's Axium Neurostimulator System for dorsal root ganglion stimulation, according to StreetInsider.com.
With the help of Ekso GT, a marine who suffered an injury in Guam, rendering him paralyzed, was able to walk, according to Momzette.
Regentis Biomaterials closed a series D investment round on Feb 5.
Advertisement
Smith & Nephew saw a large growth in short interest during the month of January, according to The Vista Voice.
A clinical trial showed Mesoblast, a global leader in cell-based medicines, and its proprietary mesenchymal precursor cell product candidate, MPC-300-IV was safe and results in early and sustained clinical responses for patients with biologic refractory rheumatoid arthritis.
Mequon, Wisc.-based Titan Spine saw a 51 percent increase in sales of its Endoskeleton interbody fusion devices in 2015.
K2M Group Holdings' stock increased 2.08 percent in shorted shares, according to FDA News Alert.
A U.S. Northwest health plan has now approved coverage and reimbursement for a ReWalk personal exoskeleton system, according to StreetInsider.com.